secwatch.observer — SEC 8-K summary
======================================

Issuer:     Verrica Pharmaceuticals Inc. (VRCA)
CIK:        0001660334
Form:       8-K
Filed at:   2023-07-27T23:59:59+00:00
Accession:  0001193125-23-196112
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Verrica posts updated corporate presentation; no specific material changes disclosed
--------------------------------------------------------------------------------

- Company filed an updated corporate presentation on its website on July 27, 2023.
- Presentation content was not fully provided in the filing; only a title page was available.
- No financial results, guidance, or strategic updates were detailed in the 8-K or exhibit.
- This is a routine Regulation FD disclosure with no new quantitative data for investors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1660334/000119312523196112/0001193125-23-196112-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1660334/000119312523196112/d523492d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-196112

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer